Phio Pharmaceuticals (PHIO) Earnings Date & Reports

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PHIO is expected to report earnings to fall 4.17% to -34 cents per share on November 05

Phio Pharmaceuticals PHIO Stock Earnings Reports

Q3'26

Est.

$-0.34

Q2'26

Missed

by $0.06

Q1'26

Missed

by $0.05

Q4'25

Beat

by $0.16

Q3'25

Missed

by $0.04

The last earnings report on August 06 showed earnings per share of -36 cents, missing the estimate of -30 cents. With 94.97K shares outstanding, the current market capitalization sits at 13.71M.

View a ticker or compare two or three

PHIO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days